Rating History for Kalvista Pharmaceuticals Inc (KALV) by Citizens

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/29/2026 Jonathan Wolleben Downgrade Market Perform
(Market Outperform)
N/A
(N/A)
19.24
(27.00)
40.33% Details